665 A PHASE I/II STUDY OF FORETINIB, AN ORAL MULTIKINASE INHIBITOR TARGETING MET, RON, AXL, TIE-2 AND VEGFR IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

Saved in:

Bibliographic Details
Published in:	Journal of hepatology Vol. 54; p. S268
Main Authors:	Yau, T, Yen, C.-J, Chen, P.-J, Chau, Y, Lencioni, R, Kallender, H, Ottesen, L.H, Poon, R.T.-P
Format:	Journal Article
Language:	English
Published:	Elsevier B.V 01-03-2011
Subjects:	Gastroenterology and Hepatology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0168-8278 1600-0641
DOI:	10.1016/S0168-8278(11)60667-3